Manessa Letaille

Manessa Letaille has a strong background in the field of precision medicine and molecular diagnostics. manessa is the founder and partner of Predicine, a global molecular insights company focused on advancing precision medicine in oncology and infectious diseases. In this role, they have developed and launched a portfolio of molecular diagnostic assays using liquid biopsy technology.

Prior to Predicine, Manessa worked as the Journal of Circulating Biomarkers, where they defined the strategic scope and built an international scientific community in the field of circulating biomarkers.

Earlier in their career, Manessa was a scientist and biomarker team lead at Genentech, where they spearheaded the co-development efforts of drugs and companion diagnostics in oncology.

manessa also briefly worked as a laboratory head at a company called 賀華.

Manessa Letaille has a Bachelor's degree in Medical Science Major from the National University of Singapore. Following this, they pursued a Postdoctoral Fellowship in Medical Science Major at Harvard Medical School. However, the specific years of these educational experiences are not provided.